Table 2.
Cardiac and liver magnetic resonance imaging T2* values of patients with β-thalassemia major under the combination therapy of deferiprone and deferasirox.
| Cases | Before combination therapy | After combination therapy | Difference between before and after | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Heart | Liver | Heart | Liver | Heart | Liver | ||||
| T2* (ms) | T2* (ms) | LIC (mg/gr/dw) | T2* (ms) | T2* (ms) | LIC (mg/gr/dw) | T2* (ms) * | T2* (ms) ** | LIC (mg/gr/dw) *** | |
| 1 | 6.95 | 1.69 | 8.20 | 7.16 | 2.06 | 6.64 | +0.21 | +0.37 | –1.56 |
| 2 | 16.46 | 1.12 | 12.72 | 22.28 | 1.78 | 7.76 | +5.82 | +0.66 | –4.96 |
| 3 | 11.16 | 3.95 | 3.31 | 14.39 | 5.65 | 2.65 | +3.23 | +1.7 | –0.66 |
| 4 | 10.87 | 1.59 | 8.76 | 18.4 | 1.81 | 7.62 | +7.53 | +0.22 | –7.62 |
| 5 | 7.46 | 2.12 | 6.44 | 21.48 | 3.81 | 3.45 | +14.02 | +1.69 | –2.99 |
| 6 | 47.22 | 2.23 | 6.1 | 20.52 | 3.08 | 4.32 | –26.7 | +0.85 | –1.78 |
LIC, liver iron concentration; Ms, millisecond.
*p<0.9,
**p<0.01,
***p<0.01.